IONIS PHARMACEUTICALS INC — Director's Dealing 2020

Mar 27, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IONIS PHARMACEUTICALS INC (IONS)
CIK: 0000874015
Period of Report: 2020-03-25

Reporting Person: CROOKE STANLEY T (Director, Exec Chairman of the Board)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-03-25	Common Stock	S	15000	$47.00	Disposed	41935	Direct
2020-03-25	Common Stock	S	1000	$47.00	Disposed	5581	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	700391	Indirect

Footnotes

F1: Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on January 2, 2020.

F2: Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person's wife on January 2, 2020.